Do We Get Samples of the Report?

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

How to Buy a Market Report?

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

In Which Format Will I Get the Report?

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

In How Much Time I will Get the Report After Purchase?

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

How Can I Get the Report Customized?

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

How Much Will It Cost to Get a Report Customized?

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

Can I Buy Only a Particular Segment of the Study?

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Is There Any Available Discount?

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

Which Services Are Complimentary Before Purchasing the Report?

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Will I Receive a Bill or Invoice for the Report Purchased?

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

What If I am Unable to Find the Report in the Catalog?

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

How Often Are the Existing Studies Updated?

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

What If the Report Does Not Contain the Information I Want?

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Is the Payment Refundable?

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

What If the Payment Fails?

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Can I Avail the Report of a Particular Country/Region?

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Do You Offer Support After Purchase?

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.

Portola Pharmaceuticals Inc (PTLA) - Financial and Strategic SWOT Analysis Review

DESCRIPTION

TABLE OF CONTENTS

RELATED REPORTS

SAMPLE REQUEST

REVIEWS

DESCRIPTION

Portola Pharmaceuticals Inc (PTLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Portola Pharmaceuticals Inc (Portola Pharmaceuticals) is a biopharmaceutical company that discovers, and develops therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. The companys products portfolio include Betrixaban, an oral once-daily Factor Xa inhibitor anticoagulant that inhibits the activity of Factor Xa; andexanet alfa, a recombinant protein designed to reverse anticoagulant activity of both direct and indirect Factor Xa inhibitors; and cerdulatinib, an oral, dual Syk-JAK inhibitor in development to treat hematologic cancers. Portola Pharmaceuticals provides compounds using biomarker and genetic approaches for clinical, regulatory and commercial purpose of life-saving therapies therapies. The company works in collaboration with other pharmaceutical and biotechnology companies for the clinical development of its lead candidates. Portola Pharmaceuticals is headquartered in South San Francisco, California, the US.

Portola Pharmaceuticals Inc Key Recent Developments

May 06,2020: Alexion to buy Portola Pharmaceuticals for $1.41bn
Mar 18,2020: Portola Pharmaceuticals announces proactive steps supporting public health efforts to combat coronavirus (COVID-19)
Feb 26,2020: Portola Pharmaceuticals reports fourth quarter and full-year 2019 financial results and provides corporate update
Feb 03,2020: Portola Pharmaceuticals appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical Officer
Jan 09,2020: Portola announces preliminary full year 2019 Andexxa Global net revenues of approximately $111 million

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

TABLE OF CONTENTS

Section 1 - About the Company
Portola Pharmaceuticals Inc - Key Facts
Portola Pharmaceuticals Inc - Key Employees
Portola Pharmaceuticals Inc - Key Employee Biographies
Portola Pharmaceuticals Inc - Major Products and Services
Portola Pharmaceuticals Inc - History
Portola Pharmaceuticals Inc - Company Statement
Portola Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Portola Pharmaceuticals Inc - Business Description
R&D Overview
Portola Pharmaceuticals Inc - Corporate Strategy
Portola Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Portola Pharmaceuticals Inc - Strengths
Portola Pharmaceuticals Inc - Weaknesses
Portola Pharmaceuticals Inc - Opportunities
Portola Pharmaceuticals Inc - Threats
Portola Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Portola Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Portola Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Portola Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 06, 2020: Alexion to buy Portola Pharmaceuticals for $1.41bn
Mar 18, 2020: Portola Pharmaceuticals announces proactive steps supporting public health efforts to combat coronavirus (COVID-19)
Feb 26, 2020: Portola Pharmaceuticals reports fourth quarter and full-year 2019 financial results and provides corporate update
Feb 03, 2020: Portola Pharmaceuticals appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical Officer
Jan 09, 2020: Portola announces preliminary full year 2019 Andexxa Global net revenues of approximately $111 million
Dec 23, 2019: Portola Pharmaceuticals to webcast corporate update on January 14, 2020
Dec 17, 2019: Portola Pharmaceuticals to support new American Heart Association initiative to address hemorrhagic stroke
Nov 05, 2019: Portola Pharmaceuticals reports third quarter 2019 financial results and provides corporate update
Sep 19, 2019: Portola Pharmaceuticals appoints Ted W. Love, M.D., to its Board of Directors
Aug 07, 2019: Portola Pharmaceuticals reports second quarter 2019 financial results and provides corporate update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

Portola Pharmaceuticals Inc, Key Facts
Portola Pharmaceuticals Inc, Key Employees
Portola Pharmaceuticals Inc, Key Employee Biographies
Portola Pharmaceuticals Inc, Major Products and Services
Portola Pharmaceuticals Inc, History
Portola Pharmaceuticals Inc, Subsidiaries
Portola Pharmaceuticals Inc, Key Competitors
Portola Pharmaceuticals Inc, Ratios based on current share price
Portola Pharmaceuticals Inc, Annual Ratios
Portola Pharmaceuticals Inc, Annual Ratios (Cont...1)
Portola Pharmaceuticals Inc, Interim Ratios
Portola Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Portola Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Portola Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

Portola Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Portola Pharmaceuticals Inc, Ratio Charts
Portola Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Portola Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

RELATED REPORTS

Rocket Pharmaceuticals Inc (RCKT) - Financial and Strategic SWOT Analysis Review

Rocket Pharmaceuticals Inc (Rocket Pharma), formerly Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company. It focuses on the discovery and development of novel therapeutics for the treatment of glaucoma and

USD 300 View Report

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

SAMPLE REQUEST

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

REVIEWS

There is no Reviews available

Search and Get the Latest Market Research Reports

Portola Pharmaceuticals Inc (PTLA) - Financial and Strategic SWOT Analysis Review

Rocket Pharmaceuticals Inc (RCKT) - Financial and Strategic SWOT Analysis Review

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review

FAQs